MERGERS: COMMISSION APPROVES ACQUISITION OF SANOFI'S ANIMAL HEALTH BUSINESS MERIAL BY BOEHRINGER INGELHEIM, SUBJECT TO CONDITIONS* The European Commission has approved under the EU Merger Regulation the acquisition of the animal health business of Sanofi (Merial) of France by Boehringer Ingelheim (BI) of Germany. The decision is conditional on the divestment of a number of animal health vaccines and pharmaceuticals. The proposed transaction leads to a combination of two key competitors in the development, manufacturing, marketing and sale of animal health products across the European Economic Area (EEA). The Commission's investigation focused on overlaps between BI and Merial's activities in the following areas: Biologicals: swine and
Share on
|
|
The EU Commission clears a merger subject to remedies in the animal health market (Boehringer Ingelheim / Sanofi)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.
